Acetazolamide

CAS 59-66-5 11 FDA-DMF suppliersSmall Molecule

Overview

Acetazolamide is a carbonic anhydrase inhibitor that is used to treat glaucoma, epilepsy, and altitude sickness. It reduces the formation of hydrogen and bicarbonate ions in the body, which decreases fluid pressure in the eyes and brain.

API suppliers (13)

Suppliers of Acetazolamide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • IDT AUSTRALIA LTD1 active DMF
  • IDT AUSTRALIA LTD1 active DMF
  • Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
  • IDT AUSTRALIA LTD1 active DMF
  • Zakłady Farmaceutyczne Polpharma S.A.Poland1 active DMF
  • NAKODA CHEMICALS LTDIndia1 active DMF
  • Emcure Pharmaceuticals LimitedIndia1 active DMF
  • IDT AUSTRALIA LTD1 active DMF
  • NAKODA CHEMICALS LTDIndia1 active DMF
  • Emcure Pharmaceuticals LimitedIndia1 active DMF
  • CTX LIFE SCIENCES PVT LTD1 active DMF
  • CAMBREX PROFARMACO MILANO SRLItaly
  • Taro Pharmaceutical Industries Ltd.Israel

Therapeutic areas

OphthalmologyNeurologyCardiology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.